All In Biotech

Drug Trial Radar · NCT05415137

Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

Last checked: Nov 19, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 268 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

268

Actual

Start

Sep 15, 2022

Primary completion

Jun 25, 2025

Study completion Jul 14, 2025

Sponsor

Lead sponsor
aTyr Pharma, Inc.Industry
Sponsor type
Industry
Collaborators
Kyorin Pharmaceutical Co.,Ltd
First posted
Jun 10, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, placebo-controlled, study comparing the efficacy and safety of intravenous (IV) efzofitimod 3 mg/kg and 5 mg/kg versus placebo after 48 weeks of treatment. This study will enroll adults with histologically confirmed pulmonary sarcoidosis receiving stable treatment with oral corticosteroid (OCS), with or without immunosuppressant therapy.

Conditions

  • Pulmonary Sarcoidosis

Interventions

  • Efzofitimod 3 mg/kgDrug

    Efzofitimod IV infusion every 4 weeks for a total of 12 doses

  • Efzofitimod 5 mg/kgDrug

    Efzofitimod IV infusion every 4 weeks for a total of 12 doses

  • PlaceboDrug

    Placebo IV infusion every 4 weeks for a total of 12 doses

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in mean daily oral corticosteroid (OCS) dose at Week 48Time frame: Baseline to Week 48

Locations

91 sites in 9 countries. Site status is shown where the registry gives one.

  • aTyr Investigative Site

    Birmingham, Alabama

  • aTyr Investigative Site

    Phoenix, Arizona

  • aTyr Investigative Site

    Los Angeles, California

  • aTyr Investigative Site

    Sacramento, California

  • aTyr Investigative Site

    Denver, Colorado

  • aTyr Investigative Site

    Washington D.C., District of Columbia

  • aTyr Investigative Site

    Gainesville, Florida

  • aTyr Investigative Site

    Tampa, Florida

  • aTyr Investigative Site

    Weston, Florida

  • aTyr Investigative Site

    Atlanta, Georgia

  • aTyr Investigative Site

    Chicago, Illinois

  • aTyr Investigative Site

    Chicago, Illinois

  • aTyr Investigative Site

    Louisville, Kentucky

  • aTyr Investigative Site

    New Orleans, Louisiana

  • aTyr Investigative Site

    Baltimore, Maryland

  • aTyr Investigative Site

    Boston, Massachusetts

  • aTyr Investigative Site

    Ada, Michigan

  • aTyr Investigative Site

    Detroit, Michigan

  • aTyr Investigative Site

    Minneapolis, Minnesota

  • aTyr Investigative Site

    Rochester, Minnesota

  • aTyr Investigative Site

    Jackson, Mississippi

  • aTyr Investigative Site

    St Louis, Missouri

  • aTyr Investigative Site

    Albany, New York

  • aTyr Investigative Site

    Middletown, New York

  • aTyr Investigative Site

    Durham, North Carolina

  • aTyr Investigative Site

    Greenville, North Carolina

  • aTyr Investigative Site

    Cincinnati, Ohio

  • aTyr Investigative Site

    Cleveland, Ohio

  • aTyr Investigative Site

    Oklahoma City, Oklahoma

  • aTyr Investigative Site

    Portland, Oregon

  • aTyr Investigative Site

    Philadelphia, Pennsylvania

  • aTyr Investigative Site

    Charleston, South Carolina

  • aTyr Investigative Site

    Dickson, Tennessee

  • aTyr Investigative Site

    Dallas, Texas

  • aTyr Investigative Site

    Dallas, Texas

  • aTyr Investigative Site

    Houston, Texas

  • aTyr Investigative Site

    Salt Lake City, Utah

  • aTyr Investigative Site

    Falls Church, Virginia

  • aTyr Investigative Site

    Richmond, Virginia

  • aTyr Investigative Site

    São Bernardo do Campo, Brazil

Showing 40 of 91 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.